Lung tumor–infiltrating T reg have divergent transcriptional profiles and function linked to checkpoint blockade response
Science Immunology · 2023
DOI: 10.1126/sciimmunol.adg1487 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, 2023. Verfasst von Arbor G Dykema und 38 weiteren Autor:innen. Beteiligte Einrichtung: Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins School of Medicine, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Regulatory T cells (T reg ) are conventionally viewed as suppressors of endogenous and therapy-induced antitumor immunity; however, their role in modulating responses to immune checkpoint blockade (ICB) is unclear. In this study, we integrated single-cell RNA-seq/T cell receptor sequencing (TCRseq) of >73,000 tumor-infiltrating T reg (TIL-T reg ) from anti–PD-1–treated and treatment-naive non–small cell lung cancers (NSCLC) with single-cell analysis of tumor-associated antigen (TAA)–specific T reg derived from a murine tumor model. We identified 10 subsets of human TIL-T reg , most of which have high concordance with murine TIL-T reg subsets. Only one subset selectively expresses high levels of TNFRSF4 (OX40) and TNFRSF18 (GITR), whose engangement by cognate ligand mediated proliferative programs and NF-κB activation, as well as multiple genes involved in T reg suppression, including LAG3 . Functionally, the OX40 hi GITR hi subset is the most highly suppressive ex vivo, and its higher representation among total TIL-T reg correlated with resistance to PD-1 blockade. Unexpectedly, in the murine tumor model, we found that virtually all TIL-T reg –expressing T cell receptors that are specific for TAA fully develop a distinct T H 1-like signature over a 2-week period after entry into the tumor, down-regulating FoxP3 and up-regulating expression of TBX21 ( Tbet) , IFNG , and certain proinflammatory granzymes. Transfer learning of a gene score from the murine TAA-specific T H 1-like T reg subset to the human single-cell dataset revealed a highly analogous subcluster that was enriched in anti–PD-1–responding tumors. These findings demonstrate that TIL-T reg partition into multiple distinct transcriptionally defined subsets with potentially opposing effects on ICB-induced antitumor immunity and suggest that TAA-specific TIL-T reg may positively contribute to antitumor responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins School of Medicine, Baltimore, MD, USA.
- The Mark Foundation Center for Advanced Genomics and Imaging, Johns Hopkins School of Medicine, Baltimore, MD, USA.
- Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.
- Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
- CM Cherry Consulting, Baltimore, MD, USA.
- Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, 27710, USA.
ORCID-Profile: Arbor G Dykema, Laurene S Cheung, Sydney Connor, Zhen Zeng, Christopher M Cherry, Taibo Li, Marni Nishimoto, Andrew J Munoz, Wentao Zhan, Marisa Mitchell-Flack, Luke M Tomasovic, Derek VanDyke, Jamie B Spangler, Valsamo Anagnostou, Stephen Yang, Jonathan Spicer, Janis Taube, Patrick M Forde, Srinivasan Yegnasubramanian, Hongkai Ji, Drew M Pardoll, Kellie N Smith
Förderung
- NHGRI NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
- NIBIB NIH HHS
Zitieren
APA
Dykema, A. G., Zhang, J., Cheung, L. S., Connor, S., Zhang, B., Zeng, Z., Cherry, C. M., Li, T., Caushi, J. X., Nishimoto, M., Munoz, A. J., Ji, Z., Hou, W., Zhan, W., Singh, D., Zhang, T., Rashid, R., Mitchell-Flack, M., Bom, S., …, & Smith, K. N. (2023). Lung tumor–infiltrating T reg have divergent transcriptional profiles and function linked to checkpoint blockade response. Science Immunology. https://doi.org/10.1126/sciimmunol.adg1487
Vancouver
Dykema AG, Zhang J, Cheung LS, Connor S, Zhang B, Zeng Z, et al. Lung tumor–infiltrating T reg have divergent transcriptional profiles and function linked to checkpoint blockade response. Science Immunology. 2023. doi:10.1126/sciimmunol.adg1487
BibTeX
@article{Dykema2023,
author = {Dykema, Arbor G and Zhang, Jiajia and Cheung, Laurene S and Connor, Sydney and Zhang, Boyang and Zeng, Zhen and Cherry, Christopher M and Li, Taibo and Caushi, Justina X and Nishimoto, Marni and Munoz, Andrew J and Ji, Zhicheng and Hou, Wenpin and Zhan, Wentao and Singh, Dipika and Zhang, Tianbei and Rashid, Rufiaat and Mitchell-Flack, Marisa and Bom, Sadhana and Tam, Ada and Ionta, Nick and Aye, Thet H K and Wang, Yi and Sawosik, Camille A and Tirado, Lauren E and Tomasovic, Luke M and VanDyke, Derek and Spangler, Jamie B and Anagnostou, Valsamo and Yang, Stephen and Spicer, Jonathan and Rayes, Roni and Taube, Janis and Brahmer, Julie R and Forde, Patrick M and Yegnasubramanian, Srinivasan and Ji, Hongkai and Pardoll, Drew M and Smith, Kellie N},
title = {Lung tumor–infiltrating T reg have divergent transcriptional profiles and function linked to checkpoint blockade response},
journal = {Science Immunology},
year = {2023},
doi = {10.1126/sciimmunol.adg1487}
}
EUVIMED